Previous research has highlighted that H19 confers resistance to conventional therapies and promotes carcinogenesis through its oncogenic function in numerous cancers such as lung, bladder, breast, and gastrointestinal malignancies [18, 19, 23]. This evidence concerns the gene H19 and cancer.